Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus

Discrepancy in Vancomycin AUC/MIC Ratio Targeted Attainment Based upon the Susceptibility Testing in Staphylococcus aureus

This study demonstrated a statistically significant difference in vancomycin minimum inhibitory concentration (MIC) for Staphylococcus aureus between a common automated system (Vitek 2) and the E-test method in patients with S. aureus bloodstream infections. At an area under the serum concentration...

Full description

Bibliographic Details
Main Authors:	Seenae Eum, Robert L. Bergsbaken, Craig L. Harvey, J. Bryan Warren, John C. Rotschafer
Format:	Article
Language:	English
Published:	MDPI AG 2016-09-01
Series:	Antibiotics
Subjects:	vancomycin MIC Staphylococcus aureus susceptibility testing
Online Access:	http://www.mdpi.com/2079-6382/5/4/34

Similar Items

Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease
by: Ahmad Khoei, et al.
Published: (2019-01-01)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
by: Wasan Katip, et al.
Published: (2021-08-01)

Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia
by: Sameerah Aljohani, et al.
Published: (2020-10-01)

Automated Susceptibility Testing With Vitek 2 Compared to MicroScan Reduces Vancomycin Alternative Therapy For Methicillin-Resistant Staphylococcus Aureus Bacteremia
by: Dusten T. Rose, et al.
Published: (2022-04-01)

Practical approaches to improve vancomycin-related patient outcomes in pediatrics- an alternative strategy when AUC/MIC is not feasible
by: Kashif Hussain, et al.
Published: (2022-08-01)

Effect of different sub MIC concentrations of penicillin, vancomycin and ceftazidime on morphology and some biochemical properties of Staphylococcus aureus and Pseudomonas aeruginosa isolates
by: Bahram Amini, et al.
Published: (2009-03-01)

Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
by: Ayda Esmaeili, et al.
Published: (2021-06-01)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
by: Jose Maria Aguado, et al.
Published: (2011-06-01)

Decreased vancomycin MICs among methicillin-resistant Staphylococcus aureus clinical isolates at a Chinese tertiary hospital over a 12-year period
by: Chaohui Lu, et al.
Published: (2016-10-01)

Different Antimicrobial Susceptibility Testing Methods to Determine Vancomycin Susceptibility and MIC for <i>Staphylococcus aureus</i> with Reduced Vancomycin Susceptibility
by: Hae-Sun Chung, et al.
Published: (2022-03-01)

Evaluation of Real-World Vancomycin Dosing and Attainment of Therapeutic Drug Monitoring Targets
by: Nicole Bradley, et al.
Published: (2023-06-01)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Curus Azimi, et al.
Published: (2012-10-01)

The Synergism Effect Of Cefepime And Vancomycin Against Coagulse Positive And Negative Methiciline Resistant Staphylococci
by: Hossein Dargahi, et al.
Published: (2012-07-01)

Evaluation of traditional initial vancomycin dosing versus utilizing an electronic AUC/MIC dosing program
by: Kerri A. McGrady, et al.
Published: (2020-09-01)

Evaluation of polymyxin B AUC/MIC ratio for dose optimization in patients with carbapenem-resistant Klebsiella pneumoniae infection
by: Peile Wang, et al.
Published: (2023-08-01)

The relationship between vancomycin AUC/MIC and trough concentration, age, dose, renal function in Chinese critically ill pediatric patients
by: Jihui Chen, et al.
Published: (2021-12-01)

Association of vancomycin trough concentration on the treatment outcome of patients with bacteremia caused by Enterococcus species
by: Yujin Sohn, et al.
Published: (2021-10-01)

Effectiveness of Disc Diffusion Method for Vancomycin Sensitivity Testing of Staphylococcus aureus [Letter]
by: Kumar N, et al.
Published: (2022-03-01)

Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients
by: Mohd Makmor-Bakry, et al.
Published: (2019-08-01)

Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia
by: Eliel Nham, et al.
Published: (2022-08-01)

In Vitro Activity of Vancomycin, Teicoplanin, Linezolid and Daptomycin Against Methicillin-Resistant Staphylococcus aureus Isolates Collected from Chinese Hospitals in 2018–2020
by: Xu Y, et al.
Published: (2021-12-01)

Molecular characterisation and epidemiology of transmission of intraoperative Staphylococcus aureus isolates stratified by vancomycin minimum inhibitory concentration (MIC)
by: Brent Hadder, et al.
Published: (2022-12-01)

Characteristics and calculations of paired vancomycin measurements for determination of 24-h area-under-curve (AUC)
by: Yutao Deng, et al.
Published: (2023-03-01)

Treatment of Intracranial Infection Caused by Methicillin-Resistant Staphylococcus epidermidis with Linezolid Following Poor Outcome of Vancomycin Therapy: A Case Report and Literature Review
by: Fu X, et al.
Published: (2021-07-01)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
by: Diana Panesso, et al.
Published: (2015-10-01)

Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus
by: Qiwen Hu, et al.
Published: (2016-10-01)

Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures
by: Luiza Pinheiro, et al.
Published: (2014-11-01)

Vancomycin AUC-Based Dosing Practices in a Non-Teaching Community Hospital and Associated Outcomes: A One-Year Survey of Uniform Targets for Infections with or without MRSA
by: Iftekharul Islam
Published: (2024-01-01)

Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis
by: Hayato Mitaka, et al.
Published: (2019-08-01)

Evaluating vancomycin susceptibility in Staphylococcus aureus
by: Mimica MJ, et al.
Published: (2016-09-01)

Reconstruction of the Vancomycin-Susceptible Staphylococcus aureus Phenotype From a Vancomycin-Intermediate S. aureus XN108
by: Huagang Peng, et al.
Published: (2018-11-01)

Determination of mic values of various antimicrobial agents and presence of resistance genes in pasteurella multocida strains isolated from bovine
by: Ozgul GULAYDIN, et al.
Published: (2021-02-01)

The vanRCd Mutation 343A>G, Resulting in a Thr115Ala Substitution, Is Associated with an Elevated Minimum Inhibitory Concentration (MIC) of Vancomycin in Clostridioides difficile Clinical Isolates from Florida
by: Ishani Wickramage, et al.
Published: (2023-06-01)

Multicenter Italian Study on “In Vitro Activities” of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip
by: Lo Cascio G, et al.
Published: (2022-10-01)

Evaluation of Vancomycin Minimum Inhibitory Concentration in the clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA)
by: Anitha T.K., et al.
Published: (2019-09-01)

Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients
by: Ronaldo Morales Junior, et al.
Published: (2023-11-01)

Diverse Roles of TgMIC1/4/6 in the Toxoplasma Infection
by: Jinjin Zhu, et al.
Published: (2021-06-01)

Target Attainment and Clinical Efficacy for Vancomycin in Neonates: Systematic Review
by: Marta Mejías-Trueba, et al.
Published: (2021-03-01)

Prevalence of Vancomycin Resistance in Methicillin-Resistant Staphylococcus Aureus
by: Parviz Mohajeri, et al.
Published: (2014-12-01)

Protective Immunity Induced by TgMIC5 and TgMIC16 DNA Vaccines Against Toxoplasmosis
by: Yu-Chao Zhu, et al.
Published: (2021-09-01)